Discovery of a Highly Subtype-Selective AURKA PROTAC Degrader (CT3) with Superior Activity to the Inhibitor for Hematological Malignancies.
- DOI
- 10.1021/acs.jmedchem.6c00805
- Published
- 2026 Aug 13
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c00805,
title = {Discovery of a Highly Subtype-Selective AURKA PROTAC Degrader (CT3) with Superior Activity to the Inhibitor for Hematological Malignancies.},
author = {Ye Y and Feng Y and Wang H and Xu L and Zhu Q and Peng L and Zhang Z and Chen TG},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c00805},
url = {https://doi.org/10.1021/acs.jmedchem.6c00805}
}RIS
TY - JOUR TI - Discovery of a Highly Subtype-Selective AURKA PROTAC Degrader (CT3) with Superior Activity to the Inhibitor for Hematological Malignancies. AU - Ye Y AU - Feng Y AU - Wang H AU - Xu L AU - Zhu Q AU - Peng L AU - Zhang Z AU - Chen TG PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c00805 UR - https://doi.org/10.1021/acs.jmedchem.6c00805 ER -
APA
Y, Y., Y, F., H, W., L, X., Q, Z., L, P., Z, Z., & TG, C. (2026). Discovery of a Highly Subtype-Selective AURKA PROTAC Degrader (CT3) with Superior Activity to the Inhibitor for Hematological Malignancies.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00805
Source records
- pubmed · retrieved 2026-09-27T12:00:53.188Z
- europe-pmc · retrieved 2026-09-27T12:00:53.208Z